| Catalog Number | YR1172 | 
																		| Alias | 科研级 Tefibazumab ( 替非组单抗 ), Anti-Fibrin-binding Surface Epitope Clumping Factor A Recombinant Antibody, Research Grade Tefibazumab | 
																		| Size | 1mg, 5mg | 
																		| Molecular Name | Tefibazumab | 
																		| CAS Number | 521079-87-8 | 
																		| Target | Fibrin-binding surface epitope clumping factor A[Staphylococcus aureus] | 
																		| Antibody Isotype | IgG1 Kappa | 
																		| Clonity | Monoclonal | 
																		| Concentration | 1mg/ml | 
																		| Purity | >95% as determined by SDS-PAGE | 
																		| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. | 
																		| Formulation | PBS, pH7.5 | 
																		| Shipping Condition | Shipped on ice packs. | 
																		| Background | Tefibazumab (named Aurexis but not approved) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in a phase 2a patients with cystic fibrosis and of methicillin-resistant S. aureus. | 
																		| Application | FCM, IP, ELISA, Neut, FuncS, IF | 
																		| Remarks | This product is for research use only. |